$1.61
+0.08 (+5.23%)
Open$1.54
Previous Close$1.53
Day High$1.63
Day Low$1.51
52W High$12.37
52W Low$1.36
Volume—
Avg Volume186.5K
Market Cap12.61M
P/E Ratio—
EPS$-1.87
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+1,105.6% upside
Current
$1.61
$1.61
Target
$19.41
$19.41
$13.09
$19.41 avg
$19.72
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.84M | 1.80M | 22.16M |
| Net Income | -13,842,956 | -7,879,243 | 3.56M |
| Profit Margin | -487.1% | -462.7% | 16.1% |
| EBITDA | -14,824,632 | -8,906,779 | 4.85M |
| Free Cash Flow | — | — | 3.49M |
| Rev Growth | +58.1% | +58.1% | +9.7% |
| Debt/Equity | — | — | 0.13 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |